Japanese
close

FI (list display)

  • G01N33/00
    		•  Investigating or analysing materials by specific methods not covered by groups G01N 1/00-G01N 31/00 HB CC 2G055
  • G01N33/00@A
    		•  Analysing solid materials HB CC 2G055
  • G01N33/00@B
    		•  Analysing liquid materials HB CC 2G055
  • G01N33/00@C
    		•  Analysing gaseous materials HB CC 2G055
  • G01N33/00@D
    		•  Analysing substance materials HB CC 2G055
  • G01N33/00@Z
    		•  Others HB CC 2G055
  • G01N33/02
    		•  .Food HB CC 2G055
  • G01N33/03
    		•  ..Edible oils or edible fats [4] HB CC 2G055
  • G01N33/04
    		•  ..Dairy products HB CC 2G055
  • G01N33/06
    		•  ...Determining fat content, e.g. by butyrometer HB CC 2G055
  • G01N33/08
    		•  ..Eggs, e.g. by candling HB CC 2G055
  • G01N33/10
    		•  ..Starch-containing substances, e.g. dough HB CC 2G055
  • G01N33/12
    		•  ..Meat; fish HB CC 2G055
  • G01N33/14
    		•  ..Beverages HB CC 2G055
  • G01N33/15
    		•  .Medicinal preparations [3] HB CC 2G055
  • G01N33/15@A
    		•  Collapsing tests or eluding tests of tablets HB CC 2G055
  • G01N33/15@B
    		•  Testing antibiotics HB CC 2G055
  • G01N33/15@C
    		•  Testing agricultural chemicals HB CC 2G055
  • G01N33/15@Z
    		•  Others HB CC 2G055
  • G01N33/18
    		•  .Water HB CC 2G055
  • G01N33/18@A
    		•  Related to suspended substances HB CC 2G055
  • G01N33/18@B
    		•  Related to organic impurities HB CC 2G055
  • G01N33/18@C
    		•  Related to electrolytes HB CC 2G055
  • G01N33/18@D
    		•  Related to dissolved oxygen HB CC 2G055
  • G01N33/18@E
    		•  Toxicity test, e.g. by using fish HB CC 2G055
  • G01N33/18@F
    		•  Involving microorganisms HB CC 2G055
  • G01N33/18@Z
    		•  Others HB CC 2G055
  • G01N33/18,101
    		•  ..General investigations HB CC 2G055
  • G01N33/18,102
    		•  ..Oxygen demand, e.g. ozone consumption HB CC 2G055
  • G01N33/18,103
    		•  ...Total oxygen demand [TOD] HB CC 2G055
  • G01N33/18,104
    		•  ...Chemical oxygen demand [COD] HB CC 2G055
  • G01N33/18,105
    		•  ...Biological oxygen demand [BOD] HB CC 2G055
  • G01N33/18,106
    		•  ..Characterised by structures of devices HB CC 2G055
  • G01N33/18,106@A
    		•  Water sampling devices HB CC 2G055
  • G01N33/18,106@B
    		•  Pre-processing devices HB CC 2G055
  • G01N33/18,106@C
    		•  Supporting detectors HB CC 2G055
  • G01N33/18,106@D
    		•  Buoys for inspecting water quality HB CC 2G055
  • G01N33/18,106@E
    		•  Preventing contamination of detectors HB CC 2G055
  • G01N33/18,106@Z
    		•  Others HB CC 2G055
  • G01N33/20
    		•  .Metals [2019.01] HB CC 2G055
  • G01N33/20,100
    		•  ..Metal analysis of solid form (G01N 33/202 takes precedence) HB CC 2G055
  • G01N33/202
    		•  ..Constituents thereof HB CC 2G055
  • G01N33/2022
    		•  ...Non-metallic constituents HB CC 2G055
  • G01N33/2025
    		•  ....Gaseous constituents HB CC 2G055
  • G01N33/2028
    		•  ...Metallic constituents HB CC 2G055
  • G01N33/204
    		•  ..Structure thereof, e.g. crystal structure HB CC 2G055
  • G01N33/2045
    		•  ...Defects [2019.01] HB CC 2G055
  • G01N33/2045,100
    		•  ....Corrosion, deterioration HB CC 2G055
  • G01N33/205
    		•  ..in liquid state, e.g. molten metals [2019.01] HB CC 2G055
  • G01N33/205,100
    		•  ...Molten steel HB CC 2G055
  • G01N33/205,110
    		•  ....collecting molten steel samples HB CC 2G055
  • G01N33/205,111
    		•  .....collection containers HB CC 2G055
  • G01N33/205,112
    		•  .....mounting/dismounting, up/down, conveyance of sublance HB CC 2G055
  • G01N33/205,200
    		•  ...Liquid metal, e.g. mercury HB CC 2G055
  • G01N33/207
    		•  ..Welded or soldered joints; Solderability HB CC 2G055
  • G01N33/208
    		•  ..Coatings, e.g. platings HB CC 2G055
  • G01N33/22
    		•  .Fuels; explosives HB CC 2G055
  • G01N33/22@A
    		•  Solid fuels HB CC 2G055
  • G01N33/22@B
    		•  Liquid fuels HB CC 2G055
  • G01N33/22@C
    		•  .By using chemical methods HB CC 2G055
  • G01N33/22@D
    		•  ..By using chemical indicators HB CC 2G055
  • G01N33/22@E
    		•  Gaseous fuels HB CC 2G055
  • G01N33/22@Z
    		•  Others HB CC 2G055
  • G01N33/24
    		•  .Earth materials (G01N 33/42 takes precedence) HB CC 2G055
  • G01N33/24@A
    		•  Ores, slugs HB CC 2G055
  • G01N33/24@B
    		•  Soil, sands, compost HB CC 2G055
  • G01N33/24@C
    		•  .Testing physical properties HB CC 2G055
  • G01N33/24@D
    		•  .testing chemical or electrical properties HB CC 2G055
  • G01N33/24@E
    		•  ..Measuring moisture content HB CC 2G055
  • G01N33/24@Z
    		•  Others HB CC 2G055
  • G01N33/26
    		•  .Oils; viscous liquids; paints; inks (G01N 33/22 takes precedence) HB CC 2G055
  • G01N33/28
    		•  ..Oils (edible oils or edible fats G01N 33/03) [4] HB CC 2G055
  • G01N33/30
    		•  ...for lubricating properties HB CC 2G055
  • G01N33/32
    		•  ..Paints; inks HB CC 2G055
  • G01N33/34
    		•  .Paper HB CC 2G055
  • G01N33/36
    		•  .Textiles HB CC 2G055
  • G01N33/36@A
    		•  Cloths HB CC 2G055
  • G01N33/36@B
    		•  Textiles HB CC 2G055
  • G01N33/36@Z
    		•  Others HB CC 2G055
  • G01N33/38
    		•  .Concrete; lime; mortar; gypsum; bricks; ceramics; glass HB CC 2G055
  • G01N33/40
    		•  .Grinding-materials HB CC 2G055
  • G01N33/42
    		•  .Road-making materials (G01N 33/38 takes precedence) HB CC 2G055
  • G01N33/44
    		•  .Resins; plastics; rubber; leather HB CC 2G055
  • G01N33/46
    		•  .Wood HB CC 2G055
  • G01N33/48
    		•  .Biological material, e.g. blood, urine (G01N 33/02, G01N 33/26, G01N 33/44, G01N 33/46?take precedence); Haemocytometers (counting blood corpuscules distributed over a surface by scanning the surface G06M 11/02 ) [3, 4] HB CC 2G045
  • G01N33/48@A
    		•  Pre-processing HB CC 2G045
  • G01N33/48@B
    		•  .Pre-processing of blood HB CC 2G045
  • G01N33/48@C
    		•  ..By using centrifugal separation HB CC 2G045
  • G01N33/48@D
    		•  ..Blood separators HB CC 2G045
  • G01N33/48@H
    		•  ..Separating blood serums in general HB CC 2G045
  • G01N33/48@J
    		•  ..Centrifugal tubes HB CC 2G045
  • G01N33/48@K
    		•  ..Blood coagulants or anticoagulants HB CC 2G045
  • G01N33/48@E
    		•  .Containers for somatology inspections HB CC 2G045
  • G01N33/48@F
    		•  ..For inspecting urine HB CC 2G045
  • G01N33/48@G
    		•  ..for fecal examination HB CC 2G045
  • G01N33/48@L
    		•  ..For inspecting phlegm HB CC 2G045
  • G01N33/48@M
    		•  Identifying cells HB CC 2G045
  • G01N33/48@N
    		•  Animal or plant tests HB CC 2G045
  • G01N33/48@P
    		•  Dying cells, preparations in general HB CC 2G045
  • G01N33/48@Q
    		•  .Applying cells HB CC 2G045
  • G01N33/48@R
    		•  .Embedding cells, freezing cells HB CC 2G045
  • G01N33/48@S
    		•  sampling specimens HB CC 2G045
  • G01N33/48@T
    		•  Accessory devices for somatology inspections HB CC 2G045
  • G01N33/48@Z
    		•  Others HB CC 2G045
  • G01N33/483
    		•  ..Physical analysis of biological material HB CC 2G045
  • G01N33/483@A
    		•  Dynamic analyses HB CC 2G045
  • G01N33/483@B
    		•  Sound analyses HB CC 2G045
  • G01N33/483@C
    		•  Optical analyses HB CC 2G045
  • G01N33/483@D
    		•  Thermal analyses HB CC 2G045
  • G01N33/483@E
    		•  Electric, magnetic HB CC 2G045
  • G01N33/483@F
    		•  Electro-chemical analyses HB CC 2G045
  • G01N33/483@Z
    		•  Others HB CC 2G045
  • G01N33/487
    		•  ...of liquid biological material [4] HB CC 2G045
  • G01N33/49
    		•  ....blood HB CC 2G045
  • G01N33/49@A
    		•  Analysing blood corpuscles HB CC 2G045
  • G01N33/49@B
    		•  .Hematocrit HB CC 2G045
  • G01N33/49@C
    		•  .blood sedimentation meter HB CC 2G045
  • G01N33/49@E
    		•  Blood corpuscle meter HB CC 2G045
  • G01N33/49@F
    		•  .Electric analyses HB CC 2G045
  • G01N33/49@H
    		•  .Optical analyses HB CC 2G045
  • G01N33/49@G
    		•  .Devices and accessories HB CC 2G045
  • G01N33/49@J
    		•  ..calculating board HB CC 2G045
  • G01N33/49@K
    		•  Optical means HB CC 2G045
  • G01N33/49@S
    		•  Diluting solutions and means for diluting HB CC 2G045
  • G01N33/49@W
    		•  Blood gases HB CC 2G045
  • G01N33/49@X
    		•  Blood platelets HB CC 2G045
  • G01N33/49@Y
    		•  Data processing HB CC 2G045
  • G01N33/49@Z
    		•  Others HB CC 2G045
  • G01N33/493
    		•  ....urine [4] HB CC 2G045
  • G01N33/493@A
    		•  Detecting constituents in urine HB CC 2G045
  • G01N33/493@B
    		•  Urine inspecting devices HB CC 2G045
  • G01N33/493@Z
    		•  Others HB CC 2G045
  • G01N33/497
    		•  ...of gaseous biological material, e.g. breath [4] HB CC 2G045
  • G01N33/497@A
    		•  Aspirations HB CC 2G045
  • G01N33/497@B
    		•  .Bad breath HB CC 2G045
  • G01N33/497@C
    		•  Aspirations of animals and plants HB CC 2G045
  • G01N33/497@D
    		•  Odors HB CC 2G045
  • G01N33/497@Z
    		•  Others HB CC 2G045
  • G01N33/50
    		•  ..Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes other than immunological involving enzymes or microorganisms, compositions or test papers therefor; processes of forming such compositions, condition responsive control in microbiological or enzymological processes C12Q)
    		HB CC 2G045
  • G01N33/50@A
    		•  Involving uric acid HB CC 2G045
  • G01N33/50@B
    		•  Involving ammonia or amines HB CC 2G045
  • G01N33/50@C
    		•  Involving urobilinogen HB CC 2G045
  • G01N33/50@D
    		•  Involving fatty acid HB CC 2G045
  • G01N33/50@E
    		•  Involving peroxides, hydrogen peroxide HB CC 2G045
  • G01N33/50@F
    		•  Standard substance other than blood or blood serum HB CC 2G045
  • G01N33/50@G
    		•  Plaque, saliva HB CC 2G045
  • G01N33/50@H
    		•  Hair HB CC 2G045
  • G01N33/50@J
    		•  Inheritance, conception HB CC 2G045
  • G01N33/50@K
    		•  Lymphocytes of T or B cells HB CC 2G045
  • G01N33/50@L
    		•  Hemolysis HB CC 2G045
  • G01N33/50@M
    		•  Leaking blood HB CC 2G045
  • G01N33/50@N
    		•  Occult bleeding HB CC 2G045
  • G01N33/50@P
    		•  Nucleic acid HB CC 2G045
  • G01N33/50@R
    		•  Urine, component not specified HB CC 2G045
  • G01N33/50@S
    		•  Bile acid HB CC 2G045
  • G01N33/50@T
    		•  Diagnosis components HB CC 2G045
  • G01N33/50@Q
    		•  Skin HB CC 2G045
  • G01N33/50@U
    		•  Related to chromatography HB CC 2G045
  • G01N33/50@X
    		•  Related to tears, sweat, bones, eyes or phlegm HB CC 2G045
  • G01N33/50@Z
    		•  Others HB CC 2G045
  • G01N33/52
    		•  ...Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper [3] HB CC 2G045
  • G01N33/52@A
    		•  calorimetric analysis HB CC 2G045
  • G01N33/52@B
    		•  By using test papers HB CC 2G045
  • G01N33/52@C
    		•  Analysing particular chemical substances HB CC 2G045
  • G01N33/52@Z
    		•  Others HB CC 2G045
  • G01N33/53
    		•  ...Immunoassay; Biospecific binding assay; Materials therefor [4] HB CC 2G045
  • G01N33/53@A
    		•  Steroid or steroid hormone HB CC 2G045
  • G01N33/53@B
    		•  Protein hormone, polypeptide hormone HB CC 2G045
  • G01N33/53@C
    		•  .HCG HB CC 2G045
  • G01N33/53@D
    		•  Protein, polypeptide HB CC 2G045
  • G01N33/53@V
    		•  .Glyco-protein HB CC 2G045
  • G01N33/53@W
    		•  .Ribo-protein HB CC 2G045
  • G01N33/53@X
    		•  .CRP HB CC 2G045
  • G01N33/53@E
    		•  Analysing thyroid hormone and free-bonded joints with bonding protein HB CC 2G045
  • G01N33/53@F
    		•  Other hormones HB CC 2G045
  • G01N33/53@G
    		•  Medicines HB CC 2G045
  • G01N33/53@H
    		•  Vitamins or coenzymes HB CC 2G045
  • G01N33/53@J
    		•  Haptens in general HB CC 2G045
  • G01N33/53@K
    		•  Blood cells, blood types, compatibility HB CC 2G045
  • G01N33/53@L
    		•  Blood coagulating factors HB CC 2G045
  • G01N33/53@M
    		•  Nucleic acid HB CC 2G045
  • G01N33/53@N
    		•  Immunity globulin HB CC 2G045
  • G01N33/53@P
    		•  lymphokine, e.g. interferon, interleukin HB CC 2G045
  • G01N33/53@Q
    		•  Allergy HB CC 2G045
  • G01N33/53@Y
    		•  Structures, cells HB CC 2G045
  • G01N33/53@R
    		•  Involving complements, Coombs test HB CC 2G045
  • G01N33/53@U
    		•  involving avidine or bition HB CC 2G045
  • G01N33/53@S
    		•  Others subject to identification HB CC 2G045
  • G01N33/53@T
    		•  Devices not classified in other sections HB CC 2G045
  • G01N33/53@Z
    		•  Others HB CC 2G045
  • G01N33/531
    		•  ....Production of immunochemical test materials [4] HB CC 2G045
  • G01N33/531@A
    		•  Antibodies or antigens in general HB CC 2G045
  • G01N33/531@B
    		•  Test media HB CC 2G045
  • G01N33/531@Z
    		•  Others HB CC 2G045
  • G01N33/532
    		•  .....Production of labelled immunochemicals [4] HB CC 2G045
  • G01N33/532@A
    		•  Labels in general HB CC 2G045
  • G01N33/532@B
    		•  Chemical luminescence or biological luminescence labels HB CC 2G045
  • G01N33/532@Z
    		•  Others HB CC 2G045
  • G01N33/533
    		•  ......with fluorescent label [4] HB CC 2G045
  • G01N33/534
    		•  ......with radioactive label [4] HB CC 2G045
  • G01N33/535
    		•  ......with enzyme label [4] HB CC 2G045
  • G01N33/536
    		•  ....with immune complex formed in liquid phase [4] HB CC 2G045
  • G01N33/536@A
    		•  Involving label substances HB CC 2G045
  • G01N33/536@B
    		•  .Radioactive label HB CC 2G045
  • G01N33/536@C
    		•  .Enzyme label HB CC 2G045
  • G01N33/536@D
    		•  .Fluorescent label HB CC 2G045
  • G01N33/536@E
    		•  .Other labels HB CC 2G045
  • G01N33/536@F
    		•  Optical measurements of impurities HB CC 2G045
  • G01N33/536@Z
    		•  Others HB CC 2G045
  • G01N33/537
    		•  .....with separation of immune complex from unbound antigen or antibody [4] HB CC 2G045
  • G01N33/538
    		•  ......by sorbent column, particles or resin strip [4] HB CC 2G045
  • G01N33/539
    		•  ......involving precipitating reagent [4] HB CC 2G045
  • G01N33/541
    		•  .......Double or second antibody [4] HB CC 2G045
  • G01N33/542
    		•  .....with steric inhibition or signal modification, e.g. fluorescent quenching [4] HB CC 2G045
  • G01N33/542@A
    		•  By using fluorescent label HB CC 2G045
  • G01N33/542@B
    		•  By using enzyme labels HB CC 2G045
  • G01N33/542@Z
    		•  Others HB CC 2G045
  • G01N33/543
    		•  ....with an insoluble carrier for immobilising immunochemicals HB CC 2G045
  • G01N33/543,501
    		•  .....Involving label substances HB CC 2G045
  • G01N33/543,501@A
    		•  Reacting types in general HB CC 2G045
  • G01N33/543,501@B
    		•  Characterised by reacting conditions, e.g. temperature, pH, reaction time HB CC 2G045
  • G01N33/543,501@D
    		•  Characterised by reagents per se, combination thereof, e.g. for measuring plurality of specimens HB CC 2G045
  • G01N33/543,501@M
    		•  Characterised by reacting media (Additionally assign to G01N 33/531B if the medium can be used for both solid phase and liquid phase methods.) HB CC 2G045
  • G01N33/543,501@F
    		•  Characterised by B/F separating method, limited to the methods using carriers (G01N 33/537-G01N 33/541 take precedence to the liquid phase method) HB CC 2G045
  • G01N33/543,501@N
    		•  Characterised by difference in affinities between antibody and antigen HB CC 2G045
  • G01N33/543,501@P
    		•  Measuring with signal modulation, e.g. modulation of the label HB CC 2G045
  • G01N33/543,501@H
    		•  Characterised by pre-processing of specimens for measurements HB CC 2G045
  • G01N33/543,501@J
    		•  Preventing interference, non-singular bonding (Additionally assign to G01N 33/543, 525W if processing of carrier is involved; also assign to G01N 33/543, 501M if special substance is contained in the reaction media.) HB CC 2G045
  • G01N33/543,501@K
    		•  Reagent storage devices HB CC 2G045
  • G01N33/543,501@L
    		•  Characterised by compensations, targeting and the like HB CC 2G045
  • G01N33/543,501@Z
    		•  Others HB CC 2G045
  • G01N33/543,511
    		•  ......By using competing reactions HB CC 2G045
  • G01N33/543,511@A
    		•  Reacting types in general HB CC 2G045
  • G01N33/543,511@B
    		•  Characterised by reacting conditions, e.g. temperature, pH, reaction time HB CC 2G045
  • G01N33/543,511@D
    		•  Characterised by reagents per se, combination thereof, e.g. for measuring plurality of specimens HB CC 2G045
  • G01N33/543,511@M
    		•  Characterised by reacting media (Additionally assign to G01N 33/531B if the medium can be used for both solid phase and liquid phase methods.) HB CC 2G045
  • G01N33/543,511@F
    		•  Characterised by B/F separating method, limited to the methods using carriers (G01N 33/537-G01N 33/541 take precedence to the liquid phase method) HB CC 2G045
  • G01N33/543,511@N
    		•  Characterised by difference in affinities between antibody and antigen HB CC 2G045
  • G01N33/543,511@P
    		•  Measuring with signal modulation, e.g. modulation of the label HB CC 2G045
  • G01N33/543,511@H
    		•  Characterised by pre-processing of specimens for measurements HB CC 2G045
  • G01N33/543,511@J
    		•  Preventing interference, non-singular bonding (Additionally assign to G01N 33/543, 525W if processing of carrier is involved; also assign to G01N 33/543, 501M if special substance is contained in the reaction media.) HB CC 2G045
  • G01N33/543,511@K
    		•  Reagent storage devices HB CC 2G045
  • G01N33/543,511@L
    		•  Characterised by compensations, targeting and the like HB CC 2G045
  • G01N33/543,511@Z
    		•  Others HB CC 2G045
  • G01N33/543,515
    		•  ......By using non-competitive reactions HB CC 2G045
  • G01N33/543,515@A
    		•  Reacting types in general HB CC 2G045
  • G01N33/543,515@B
    		•  Characterised by reacting conditions, e.g. temperature, pH, reaction time HB CC 2G045
  • G01N33/543,515@D
    		•  Characterised by reagents per se, combination thereof, e.g. for measuring plurality of specimens HB CC 2G045
  • G01N33/543,515@M
    		•  Characterised by reacting media (Additionally assign to G01N 33/531B if the medium can be used for both solid phase and liquid phase methods.) HB CC 2G045
  • G01N33/543,515@F
    		•  Characterised by B/F separating method, limited to the methods using carriers (G01N 33/537-G01N 33/541 take precedence to the liquid phase method) HB CC 2G045
  • G01N33/543,515@N
    		•  Characterised by difference in affinities between antibody and antigen HB CC 2G045
  • G01N33/543,515@P
    		•  Measuring with signal modulation, e.g. modulation of the label HB CC 2G045
  • G01N33/543,515@H
    		•  Characterised by pre-processing of specimens for measurements HB CC 2G045
  • G01N33/543,515@J
    		•  Preventing interference, non-singular bonding (Additionally assign to G01N 33/543, 525W if processing of carrier is involved; also assign to G01N 33/543, 501M if special substance is contained in the reaction media.) HB CC 2G045
  • G01N33/543,515@K
    		•  Devised reagent storage HB CC 2G045
  • G01N33/543,515@L
    		•  Characterised by compensations, targeting and the like HB CC 2G045
  • G01N33/543,515@Z
    		•  Others HB CC 2G045
  • G01N33/543,521
    		•  ......Characterised by profiles or forms of carriers HB CC 2G045
  • G01N33/543,525
    		•  ......Characterised by processing or properties of carriers HB CC 2G045
  • G01N33/543,525@W
    		•  Characterised by processing of carriers (Also assigned to G01N 33/543, 525U if the processing involves coating.) HB CC 2G045
  • G01N33/543,525@C
    		•  Characterised by properties of carriers, e.g. granular size, matrix structures (profiles and forms G01N 33/543, 521, G01N 33/543, 561 take precedence; G01N 33/544-G01N 33/556 take precedence to those characterised by materials) HB CC 2G045
  • G01N33/543,525@U
    		•  .Devised carrier surface (Additionally assign to G01N 33/543, 525W if processing is involved) HB CC 2G045
  • G01N33/543,525@E
    		•  Debris in bonding between solid phase/antibody or antigen, antibody or antigen/label (G01N 33/547 takes precedence) HB CC 2G045
  • G01N33/543,525@G
    		•  Characterised by manufacturing solid phase reagents (for other than solid phase G01N 33/531 takes precedence; those characterised by processing or coating of carriers during manufacturing are also assigned toG01N 33/543, 525W) HB CC 2G045
  • G01N33/543,525@Z
    		•  Others HB CC 2G045
  • G01N33/543,531
    		•  ......Handling or automatic analysis of carriers HB CC 2G045
  • G01N33/543,541
    		•  ......Characterised by labels HB CC 2G045
  • G01N33/543,541@A
    		•  Magnetic labels HB CC 2G045
  • G01N33/543,541@B
    		•  Radioactive labels HB CC 2G045
  • G01N33/543,541@Z
    		•  Others HB CC 2G045
  • G01N33/543,545
    		•  .......Enzyme labels, e.g. the labels that involve enzymes for generating the signals HB CC 2G045
  • G01N33/543,545@A
    		•  Reacting types in general HB CC 2G045
  • G01N33/543,545@B
    		•  Characterised by reacting conditions, e.g. temperature, pH, reaction time HB CC 2G045
  • G01N33/543,545@D
    		•  Characterised by reagents per se, combination thereof, e.g. for measuring plurality of specimens HB CC 2G045
  • G01N33/543,545@M
    		•  Characterised by reacting media (Additionally assign to G01N 33/531B if the medium can be used for both solid phase and liquid phase methods.) HB CC 2G045
  • G01N33/543,545@F
    		•  Characterised by B/F separating method, limited to the methods using carriers (G01N 33/537-G01N 33/541 take precedence to the liquid phase method) HB CC 2G045
  • G01N33/543,545@N
    		•  Characterised by difference in affinities between antibody and antigen HB CC 2G045
  • G01N33/543,545@P
    		•  Measuring with signal modulation, e.g. by using hindrance of active portions of enzyme HB CC 2G045
  • G01N33/543,545@H
    		•  Characterised by pre-processing of specimens for measurements HB CC 2G045
  • G01N33/543,545@J
    		•  Preventing interference, non-singular bonding (Additionally assign to G01N 33/543, 565W if processing of carrier is involved; also assign to G01N 33/543, 545M if special substance is contained in the reaction media.) HB CC 2G045
  • G01N33/543,545@K
    		•  Devised reagent storage HB CC 2G045
  • G01N33/543,545@L
    		•  Characterised by compensations, targeting and the like HB CC 2G045
  • G01N33/543,545@S
    		•  Characterised by enzymes per se, bases thereof HB CC 2G045
  • G01N33/543,545@T
    		•  By using plurality of enzymes HB CC 2G045
  • G01N33/543,545@Z
    		•  Others HB CC 2G045
  • G01N33/543,551
    		•  ........By using competitive reactions HB CC 2G045
  • G01N33/543,551@A
    		•  Reacting types in general HB CC 2G045
  • G01N33/543,551@B
    		•  Characterised by reacting conditions, e.g. temperature, pH, reaction time HB CC 2G045
  • G01N33/543,551@D
    		•  Characterised by reagents per se, combination thereof, e.g. for measuring plurality of specimens HB CC 2G045
  • G01N33/543,551@M
    		•  Characterised by reacting media (Additionally assign to G01N 33/531B if the medium can be used for both solid phase and liquid phase methods.) HB CC 2G045
  • G01N33/543,551@F
    		•  Characterised by B/F separating method, limited to the methods using carriers (G01N 33/537-G01N 33/541 take precedence to the liquid phase method) HB CC 2G045
  • G01N33/543,551@N
    		•  Characterised by difference in affinities between antibody and antigen HB CC 2G045
  • G01N33/543,551@P
    		•  Measuring with signal modulation, e.g. by using hindrance of active portions of enzyme HB CC 2G045
  • G01N33/543,551@H
    		•  Characterised by pre-processing of specimens for measurements HB CC 2G045
  • G01N33/543,551@J
    		•  Preventing interference, non-singular bonding (Additionally assign to G01N 33/543, 565W if processing of carrier is involved; also assign to G01N 33/543, 551M if special substance is contained in the reaction media.) HB CC 2G045
  • G01N33/543,551@K
    		•  Devised reagent storage HB CC 2G045
  • G01N33/543,551@L
    		•  Characterised by compensations, targeting and the like HB CC 2G045
  • G01N33/543,551@S
    		•  Characterised by enzymes per se or bases thereof HB CC 2G045
  • G01N33/543,551@T
    		•  By using plurality of enzymes HB CC 2G045
  • G01N33/543,551@Z
    		•  Others HB CC 2G045
  • G01N33/543,555
    		•  ........By using non-competitive reactions HB CC 2G045
  • G01N33/543,555@A
    		•  Reacting types in general HB CC 2G045
  • G01N33/543,555@B
    		•  Characterised by reacting conditions, e.g. temperature, pH, reaction time HB CC 2G045
  • G01N33/543,555@D
    		•  Characterised by reagents per se, combination thereof, e.g. for measuring plurality of specimens HB CC 2G045
  • G01N33/543,555@M
    		•  Characterised by reacting media (Additionally assign to G01N 33/531B if the medium can be used for both solid phase and liquid phase methods.) HB CC 2G045
  • G01N33/543,555@F
    		•  Characterised by B/F separating method, limited to the methods using carriers (G01N 33/537-G01N 33/541 take precedence to the liquid phase method) HB CC 2G045
  • G01N33/543,555@N
    		•  Characterised by difference in affinities between antibody and antigen HB CC 2G045
  • G01N33/543,555@P
    		•  Measuring with signal modulation, e.g. by using hindrance of active portions of enzyme HB CC 2G045
  • G01N33/543,555@H
    		•  Characterised by pre-processing of specimens for measurements HB CC 2G045
  • G01N33/543,555@J
    		•  Preventing interference, non-singular bonding (Additionally assign to G01N 33/543, 565W if processing of carrier is involved; also assign to G01N 33/543, 555M if special substance is contained in the reaction media.) HB CC 2G045
  • G01N33/543,555@K
    		•  Devised reagent storage HB CC 2G045
  • G01N33/543,555@L
    		•  Characterised by compensations, targeting and the like HB CC 2G045
  • G01N33/543,555@S
    		•  Characterised by enzymes per se, bases thereof HB CC 2G045
  • G01N33/543,555@T
    		•  By using plurality of enzymes HB CC 2G045
  • G01N33/543,555@Z
    		•  Others HB CC 2G045
  • G01N33/543,561
    		•  ........Characterised by profiles or forms of carriers HB CC 2G045
  • G01N33/543,565
    		•  ........Characterised by processing or properties of carriers HB CC 2G045
  • G01N33/543,565@W
    		•  Characterised by profiles or forms of carriers (Additionally assign the processing related to coating to G01N 33/543, 565U) HB CC 2G045
  • G01N33/543,565@C
    		•  Characterised by properties of carriers, e.g. the granular sizes or matrix structures (profiles or forms G01N 33/543, 521, G01N 33/543, 561 take precedence; with characteristics in materials G01N 33/544-G01N 33/556 take precedence) HB CC 2G045
  • G01N33/543,565@U
    		•  Characterised by processing of carriers (Additionally assign to G01N 33/543, 565W if the processing involves coating.) HB CC 2G045
  • G01N33/543,565@E
    		•  Debris in bonding between solid phase and antibody or antigen, antibody or antigen and label (G01N 33/547 takes precedence) HB CC 2G045
  • G01N33/543,565@G
    		•  Characterised by manufacturing solid phase reagents (for other than solid phase G01N 33/531 takes precedence; those characterised by processing or coating of carriers during manufacturing are also assigned to G01N 33/543, 565W, G01N 33/543, 565U) HB CC 2G045
  • G01N33/543,565@Z
    		•  Others HB CC 2G045
  • G01N33/543,571
    		•  ........Handling or automatic analysis of carriers HB CC 2G045
  • G01N33/543,575
    		•  .......Fluorescent labels, chemical fluorescence labels HB CC 2G045
  • G01N33/543,581
    		•  .....By using cohesion reactions HB CC 2G045
  • G01N33/543,581@A
    		•  Reacting types in general HB CC 2G045
  • G01N33/543,581@B
    		•  Characterised by reacting conditions, e.g. temperature, pH, reaction time HB CC 2G045
  • G01N33/543,581@D
    		•  Characterised by reagents per se,combinations thereof, e.g. Adsorbing plurality of reagents by the carrier or using plurality of granular sizes HB CC 2G045
  • G01N33/543,581@F
    		•  Characterised by post-reaction processing of cohered particles, e.g. collection after cohesion HB CC 2G045
  • G01N33/543,581@H
    		•  Characterised by pre-processing of specimens for measurements HB CC 2G045
  • G01N33/543,581@J
    		•  Preventing interference, non-singular bonding (Additionally assign to G01N 33/543, 565W if processing of carrier is involved; also classify G01N 33/543, 555M if special substance is contained in the reaction media.) HB CC 2G045
  • G01N33/543,581@K
    		•  Characterised by devices for storing reagents HB CC 2G045
  • G01N33/543,581@L
    		•  Characterised by usage of compensation, objects and the like HB CC 2G045
  • G01N33/543,581@V
    		•  Preventing prozoning HB CC 2G045
  • G01N33/543,581@W
    		•  Characterised by properties of carriers (Additionally assign the processing related to coating to G01N 33/543, 581U.) HB CC 2G045
  • G01N33/543,581@C
    		•  Characterised by properties of carriers, e.g. granular sizes, specific gravity or electric potential (with characteristics in materials G01N 33/544-G01N 33/556 take precedence) HB CC 2G045
  • G01N33/543,581@U
    		•  .With devices on carrier surfaces (Additionally assign to G01N 33/543, 581W if it involves processing.) HB CC 2G045
  • G01N33/543,581@E
    		•  Debris in bonding between solid phase and antibody or antigen (G01N 33/547 takes precedence) HB CC 2G045
  • G01N33/543,581@G
    		•  Characterised by manufacturing cohering reagents (Additionally assign to G01N 33/543, 581W, G01N 33/543, 581U, if the manufacturing is characterised by processing or coating of carriers.) HB CC 2G045
  • G01N33/543,581@Z
    		•  Others HB CC 2G045
  • G01N33/543,583
    		•  ......Characterised by catalysts for cohesion reactions HB CC 2G045
  • G01N33/543,585
    		•  ......For observing sedimentation conditions HB CC 2G045
  • G01N33/543,587
    		•  ......For observing suspended conditions HB CC 2G045
  • G01N33/543,591
    		•  .....Carriers with plurality of structures HB CC 2G045
  • G01N33/543,593
    		•  .....By using changes in properties on the carrier surface HB CC 2G045
  • G01N33/543,595
    		•  ......By using changes in optical properties on the carrier surface HB CC 2G045
  • G01N33/543,597
    		•  .....Analysing by using flow systems HB CC 2G045
  • G01N33/544
    		•  .....the carrier being organic HB CC 2G045
  • G01N33/544@A
    		•  LiposomeRibosome HB CC 2G045
  • G01N33/544@B
    		•  Micro capsules HB CC 2G045
  • G01N33/544@Z
    		•  Others HB CC 2G045
  • G01N33/545
    		•  ......Synthetic resin [4] HB CC 2G045
  • G01N33/545@A
    		•  Involving label substances HB CC 2G045
  • G01N33/545@B
    		•  By using cohesion reactions HB CC 2G045
  • G01N33/545@Z
    		•  Others HB CC 2G045
  • G01N33/546
    		•  .......as water suspendable particles [4] HB CC 2G045
  • G01N33/547
    		•  .......with antigen or antibody attached to the carrier via a bridging agent [4] HB CC 2G045
  • G01N33/548
    		•  ......Carbohydrates, e.g. dextran [4] HB CC 2G045
  • G01N33/548@A
    		•  Involving label substances HB CC 2G045
  • G01N33/548@B
    		•  By using cohesion reactions HB CC 2G045
  • G01N33/548@Z
    		•  Others HB CC 2G045
  • G01N33/549
    		•  ......with antigen or antibody entrapped within the carrier [4] HB CC 2G045
  • G01N33/551
    		•  .....the carrier being inorganic [4] HB CC 2G045
  • G01N33/552
    		•  ......Glass or silica [4] HB CC 2G045
  • G01N33/553
    		•  ......Metal or metal coated [4] HB CC 2G045
  • G01N33/554
    		•  .....the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells [4] HB CC 2G045
  • G01N33/555
    		•  ......Red blood cell [4] HB CC 2G045
  • G01N33/556
    		•  .......Fixed or stabilised red blood cell [4] HB CC 2G045
  • G01N33/557
    		•  ....using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction [4] HB CC 2G045
  • G01N33/558
    		•  ....using diffusion or migration of antigen or antibody [4] HB CC 2G045
  • G01N33/559
    		•  .....through a gel, e.g. Ouchterlony technique [4] HB CC 2G045
  • G01N33/561
    		•  .....Immunoelectrophoresis [4] HB CC 2G045
  • G01N33/563
    		•  ....involving antibody fragments [4] HB CC 2G045
  • G01N33/564
    		•  ....for pre-existing immune complex or autoimmune disease [4] HB CC 2G045
  • G01N33/564@A
    		•  Anti-nuclear factors HB CC 2G045
  • G01N33/564@B
    		•  Rheumatism factor HB CC 2G045
  • G01N33/564@Z
    		•  Others HB CC 2G045
  • G01N33/566
    		•  ....using specific carrier or receptor proteins as ligand binding reagent [4] HB CC 2G045
  • G01N33/567
    		•  .....utilising isolate of tissue or organ as binding agent [4] HB CC 2G045
  • G01N33/569
    		•  ....for microorganisms, e.g. protozoa, bacteria, viruses HB CC 2G045
  • G01N33/569@A
    		•  Protozoa or parasitic worm eumycophyta HB CC 2G045
  • G01N33/569@B
    		•  Bacteria HB CC 2G045
  • G01N33/569@C
    		•  .Haemolysis streptococcus HB CC 2G045
  • G01N33/569@D
    		•  .Pseudomonas aeruginosa HB CC 2G045
  • G01N33/569@E
    		•  .Staphylococcus HB CC 2G045
  • G01N33/569@F
    		•  .Other particular bacteria HB CC 2G045
  • G01N33/569@G
    		•  Viruses HB CC 2G045
  • G01N33/569@H
    		•  .Retro viruses, e.g. AIDS, horse contagious anaemia virus HB CC 2G045
  • G01N33/569@J
    		•  .Herpes virus HB CC 2G045
  • G01N33/569@K
    		•  .German measles virus HB CC 2G045
  • G01N33/569@L
    		•  .Other particular viruses HB CC 2G045
  • G01N33/569@Z
    		•  Others HB CC 2G045
  • G01N33/571
    		•  .....for venereal disease, e.g. syphilis, gonorrhoea, herpes [4] HB CC 2G045
  • G01N33/573
    		•  ....for enzymes or isoenzymes [4] HB CC 2G045
  • G01N33/573@A
    		•  Enzymes HB CC 2G045
  • G01N33/573@B
    		•  .Isoenzymes HB CC 2G045
  • G01N33/573@Z
    		•  Others HB CC 2G045
  • G01N33/574
    		•  ....for cancer HB CC 2G045
  • G01N33/574@A
    		•  Cancer related proteins HB CC 2G045
  • G01N33/574@E
    		•  .Carcinoembryonic antigen [CEA], alpha-fetoprotein [AFP] HB CC 2G045
  • G01N33/574@B
    		•  Cancer related substances containing saccharides HB CC 2G045
  • G01N33/574@C
    		•  Cancer virus HB CC 2G045
  • G01N33/574@D
    		•  Cancer cells HB CC 2G045
  • G01N33/574@Z
    		•  Others HB CC 2G045
  • G01N33/576
    		•  ....for hepatitis [4] HB CC 2G045
  • G01N33/576@A
    		•  Type A hepatitis HB CC 2G045
  • G01N33/576@B
    		•  Type B hepatitis HB CC 2G045
  • G01N33/576@Z
    		•  Others HB CC 2G045
  • G01N33/577
    		•  ....involving monoclonal antibodies HB CC 2G045
  • G01N33/577@A
    		•  Monoclonal antibodies in general HB CC 2G045
  • G01N33/577@B
    		•  Particular monoclonal antibodies HB CC 2G045
  • G01N33/577@Z
    		•  Others HB CC 2G045
  • G01N33/579
    		•  ...involving limulus lysate [4] HB CC 2G045
  • G01N33/58
    		•  ...involving labelled substances () [3] HB CC 2G045
  • G01N33/58@A
    		•  Related to nucleic acids HB CC 2G045
  • G01N33/58@Z
    		•  Others HB CC 2G045
  • G01N33/60
    		•  ....involving radioactive labelled substances [3] HB CC 2G045
  • G01N33/60@A
    		•  Related to autoradiography HB CC 2G045
  • G01N33/60@Z
    		•  Others HB CC 2G045
  • G01N33/62
    		•  ...involving urea [3] HB CC 2G045
  • G01N33/62@A
    		•  Containing enzymes HB CC 2G045
  • G01N33/62@Z
    		•  Others HB CC 2G045
  • G01N33/64
    		•  ...involving ketones [3] HB CC 2G045
  • G01N33/66
    		•  ...involving blood sugars, e.g. galactose HB CC 2G045
  • G01N33/66@A
    		•  Containing blood sugar HB CC 2G045
  • G01N33/66@B
    		•  Chemical substances such as reagents HB CC 2G045
  • G01N33/66@C
    		•  .Containing enzymes HB CC 2G045
  • G01N33/66@D
    		•  Devices, processes HB CC 2G045
  • G01N33/66@Z
    		•  Others HB CC 2G045
  • G01N33/68
    		•  ...involving proteins, peptides or amino acids [3] HB CC 2G045
  • G01N33/70
    		•  ...involving creatine or creatinine [3] HB CC 2G045
  • G01N33/72
    		•  ...involving blood pigments, e.g. hemoglobin, bilirubin [3] HB CC 2G045
  • G01N33/72@A
    		•  Containing hemoglobin HB CC 2G045
  • G01N33/72@B
    		•  Containing bilirubin HB CC 2G045
  • G01N33/72@Z
    		•  Others HB CC 2G045
  • G01N33/74
    		•  ...involving hormones [3] HB CC 2G045
  • G01N33/76
    		•  ....Human chorionic gonadotropin [3] HB CC 2G045
  • G01N33/78
    		•  ....Thyroid gland hormones [3] HB CC 2G045
  • G01N33/80
    		•  ...involving blood groups or blood types [3] HB CC 2G045
  • G01N33/82
    		•  ...involving vitamins [3] HB CC 2G045
  • G01N33/84
    		•  ...involving inorganic compounds or pH HB CC 2G045
  • G01N33/84@A
    		•  Related to pH HB CC 2G045
  • G01N33/84@Z
    		•  Others HB CC 2G045
  • G01N33/86
    		•  ...involving blood coagulating time [3] HB CC 2G045
  • G01N33/88
    		•  ...involving prostaglandins [3] HB CC 2G045
  • G01N33/90
    		•  ...involving iron binding capacity of blood [3] HB CC 2G045
  • G01N33/92
    		•  ...involving lipids, e.g. cholesterol HB CC 2G045
  • G01N33/92@A
    		•  Cholesterol HB CC 2G045
  • G01N33/92@B
    		•  .Containing enzymes HB CC 2G045
  • G01N33/92@C
    		•  Triglyceride HB CC 2G045
  • G01N33/92@Z
    		•  Others HB CC 2G045
  • G01N33/94
    		•  ...involving narcotics [3] HB CC 2G045
  • G01N33/96
    		•  ...involving blood or serum control standard [3] HB CC 2G045
  • G01N33/98
    		•  ...involving alcohol, e.g. ethanol in breath [4] HB CC 2G045
    TOP